Specifically, MHC-II expression on tumor cells was found to be predictive of response to anti-PD1, and it was hypothesized that they represented a subset of tumors capable of stimulating CD4 T-cells or CD8 T-cells. The gene discussed is CD8A; the disease is neoplasm.